Optimal Focus
Optimal Focus, licence 80077962: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- NUWA CARE INC.
- NPN or DIN-HM
- 80077962
- Status
- Active licence
- Licence date
- 1 June 2017
- Revision date
- 14 November 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Clupeidae - en entier Potency : 19.0 % Docosahexaenoic acid | 150.0 milligramme | Not calculated |
| L-théanine Source : L-Théanine | 100.0 milligramme | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 5.000:1 Dry plant equivalent : 125 milligramme Potency : 3.0 % Rosavins | 25.0 milligramme | Not calculated |
| Scutellaria lateriflora Source : Scutellaria lateriflora - Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 5.000:1 Dry plant equivalent : 125 milligramme | 25.0 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Eau purifiée, Stéarate de magnésium, Pullulane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 1.0 Capsule | minimum: 2.0 Jour(s) ; maximum: 2.0 Jour(s) |
Uses authorised in Canada
Source of Omega-3 fatty acids for the maintenance of good health. Helps support cognitive health and/or brain function. Helps to temporarily promote relaxation. Provides antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other drugs and/or natural health products with sedative properties is not recommended. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use.
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. If you experience irritability or insomnia, discontinue use.
- Contre-indications
Do not use if you are pregnant or breastfeeding. If you have bipolar disorder or bipolar spectrum disorder, do not use this product.
Source
Official Health Canada record, licence 80077962
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.